AstraZeneca says the approval strengthens its push to bring immunotherapy earlier into cancer treatment, where long-term cures are possible
The Taipei facility boasts 10 GMP API production lines, with a total reactor volume exceeding 350,000 liters
There are limited treatment options available for patients living with non-diabetic CKD, and the unmet need is high for new treatments to delay kidney disease progression and reduce cardiovascular risk
The trial will enroll up to 42 patients in Finland across four cohorts
The initiative will focus on creating healthier early-life environments, promoting physical activity, identifying risks early, and strengthening preparedness within primary health care systems
Lilly has long voiced concerns over mass-compounded knockoffs of its tirzepatide medicines, Mounjaro and Zepbound
The conflict is also triggering a widening public health emergency
Launches advanced bone density systems in India & Dubai
The study showed a 76% complete response (CR) rate at 12 months, rising to 95% at any time for high-risk NMIBC patients
Germany will be the first launch market
Subscribe To Our Newsletter & Stay Updated
